A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (opens ClinicalTrials.gov)
- Sponsor
- Eli Lilly and Company
- Enrolment
- 160
- Started
- 2023-10-16
- Last update
- 2026-06-29
Conditions: Obesity, Overweight
Interventions: Tirzepatide, Placebo